These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 17531556)
21. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543 [TBL] [Abstract][Full Text] [Related]
22. [The phenotype and clinical patterns of Crohn's disease in the Chinese]. Wu X; Lu XH Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):661-3. PubMed ID: 17074153 [TBL] [Abstract][Full Text] [Related]
23. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases. Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978 [TBL] [Abstract][Full Text] [Related]
24. Gene polymorphisms and serological markers of patients with active Crohn's disease in a clinical trial of antisense to ICAM-1. Yacyshyn BR; Schievella A; Sewell KL; Tami JA Clin Exp Immunol; 2005 Jul; 141(1):141-7. PubMed ID: 15958080 [TBL] [Abstract][Full Text] [Related]
25. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease. Mokrowiecka A; Gasiorowska A; Malecka-Panas E Hepatogastroenterology; 2007; 54(77):1443-8. PubMed ID: 17708273 [TBL] [Abstract][Full Text] [Related]
26. [Interest of serologic markers in inflammatory bowel disease. About 105 cases]. Fekih M; Ben Hlima S; Zitouni M; Matri S; Boubaker J; Makni S; Azza F Tunis Med; 2007 Oct; 85(10):821-8. PubMed ID: 18236802 [TBL] [Abstract][Full Text] [Related]
27. 3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn's disease in Tunisian population. Marrakchi R; Bougatef K; Moussa A; Ouerhani S; Khodjet-el-Khil H; Messai Y; Mestiri O; Najar T; Benammar-Elgaaeid A Inflamm Res; 2009 Apr; 58(4):218-23. PubMed ID: 19184350 [TBL] [Abstract][Full Text] [Related]
28. Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease. Esters N; Vermeire S; Joossens S; Noman M; Louis E; Belaiche J; De Vos M; Van Gossum A; Pescatore P; Fiasse R; Pelckmans P; Reynaert H; Poulain D; Bossuyt X; Rutgeerts P; Am J Gastroenterol; 2002 Jun; 97(6):1458-62. PubMed ID: 12094865 [TBL] [Abstract][Full Text] [Related]
29. CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients. Cruyssen BV; Peeters H; Hoffman IE; Laukens D; Coucke P; Marichal D; Cuvelier C; Remaut E; Veys EM; Mielants H; De Vos M; De Keyser F Clin Exp Immunol; 2005 May; 140(2):354-9. PubMed ID: 15807862 [TBL] [Abstract][Full Text] [Related]
30. [Anti-Saccharomyces cerevisiae antibodies in patients with Crohn's disease]. Barta Z; Csípö I; Antal-Szalmás P; Sipka S; Szabó G; Szegedi G Orv Hetil; 2001 Oct; 142(42):2303-7. PubMed ID: 11760647 [TBL] [Abstract][Full Text] [Related]
31. Mannose-binding lectin deficiency is not associated with anti-Saccharomyces cerevisiae antibody in Korean Crohn's disease patients. Kim YS; Kim YH; Ye BD; Park DW; Kim JW; Han DS Clin Chim Acta; 2014 Feb; 429():206-11. PubMed ID: 24374090 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis. Kim YS; Kim YH; Kim WH; Kim JS; Park YS; Yang SK; Ye BD; Jang BI; Jung SA; Jeen YT; Cheon JH; Choi YS; Choi JH; Kim BJ; Choi CH; Han DS Clin Chim Acta; 2011 Aug; 412(17-18):1527-32. PubMed ID: 21575618 [TBL] [Abstract][Full Text] [Related]
33. Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis. Preda CM; Vermeire S; Rutgeerts P; Joosens S; Diculescu M; Marica C; Ciocarlan M; Mirea V; Oproiu A Rom J Gastroenterol; 2005 Dec; 14(4):357-60. PubMed ID: 16400351 [TBL] [Abstract][Full Text] [Related]
34. Dietary antigens in Crohn's disease: antibodies to porcine pancreatic amylase. Suzuki H; Fukuda Y; Koizuka H; Tomita T; Hori K; Suzuki M; O'Morain C Am J Gastroenterol; 2008 Mar; 103(3):656-64. PubMed ID: 18028509 [TBL] [Abstract][Full Text] [Related]
35. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590 [TBL] [Abstract][Full Text] [Related]
36. Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins? Lakatos PL; Altorjay I; Mándi Y; Lakatos L; Tumpek J; Kovacs A; Molnar T; Tulassay Z; Miheller P; Palatka K; Szamosi T; Fischer S; Papp J; ; Papp M Tissue Antigens; 2008 Jun; 71(6):552-9. PubMed ID: 18397186 [TBL] [Abstract][Full Text] [Related]
39. Disease behavior in adult patients: are there predictors for stricture or fistula formation? Dotan I Dig Dis; 2009; 27(3):206-11. PubMed ID: 19786742 [TBL] [Abstract][Full Text] [Related]
40. Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study). Henriksen M; Jahnsen J; Lygren I; Aadland E; Schulz T; Vatn MH; Moum B; Scand J Gastroenterol; 2007 May; 42(5):602-10. PubMed ID: 17454881 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]